Study identifies high-impact postoperative complications in older patients undergoing hip fracture repair OAKBROOK TERRACE, Ill., March 23, 2021 (GLOBE NEWSWIRE) -- Hip fracture in older patients is common, debilitating and costly.1,2,3 A new study in the April 2021 issue of The Joint Commission Journal...

Viking Therapeutics Initiates Clinical Trial for VK5211, a Selective Androgen Receptor Modulator (SARM), for Acute Hip Fracture SAN DIEGO, Sept. 1, 2015 (GLOBE NEWSWIRE) -- Viking Therapeutics, Inc. ("Viking") (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or...